ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
진단용 효소 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 44억 9,000만 달러에서 2026년에는 47억 5,000만 달러로, CAGR 5.7%로 확대될 것으로 예상됩니다. 지난 몇 년간 성장 요인으로는 고순도 진단용 효소 공급 제한, 기존 분석법에 대한 의존도, 만성질환의 증가 추세, 생명공학 및 연구 활동의 확대, 효소 기반 진단법에 대한 인식 개선 등을 꼽을 수 있습니다.
진단용 효소 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 63억 9,000만 달러에 달하고, CAGR은 7.7%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 첨단 효소 공학 기술 개발, 디지털 헬스 플랫폼과의 진단 통합, 현장 진료 검사 도입 확대, 제약 및 생명공학 분야의 연구개발 확대, 진단 기술 혁신에 대한 정부 및 민간 자금의 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 효소 기반 진단 키트의 채택 확대, 맞춤형 의료 및 바이오마커 검출의 성장, 연구 및 생명공학 응용 분야 확대, 고특이성 및 고감도 효소에 대한 수요 증가, 현장 검사에 효소 진단의 통합 등이 있습니다.
만성질환의 유병률 증가는 향후 몇 년간 진단용 효소 시장의 성장을 견인할 것으로 예상됩니다. 만성질환이란 3개월 이상 지속되는 장기적인 건강상태를 말합니다. 진단용 효소는 의료진이 질병의 심각성을 평가하고, 치료 효과를 추적하고, 정보에 입각한 치료 계획을 조정할 수 있도록함으로써 만성질환 및 기타 의료 상태를 진단하고 지속적으로 모니터링하는 데 중요한 역할을 합니다. 예를 들어, 미국 국립의학도서관(National Library of Medicine)의 2023년 1월 기준 자료에 따르면, 미국에서 50세 이상 만성질환을 하나 이상 앓고 있는 인구는 2050년까지 99.5% 증가하여 7,152만 2,000명에서 1억 4, 266만 명에 달할 것으로 예측하고 있습니다. 266만 명에 달할 것으로 예측됩니다. 따라서 만성질환의 증가는 진단용 효소 시장의 확대에 기여하고 있습니다.
진단용 효소 시장에서 사업을 영위하는 주요 기업들은 특히 종양학 및 감염 검사 등 임상 진단 분야에서 고감도 및 절대 정량화에 대한 수요가 증가함에 따라 디지털 PCR 플랫폼과 같은 기술 혁신을 점점 더 중요하게 여기고 있습니다. 디지털 PCR(dPCR)은 시료를 수천 나노리터 규모의 반응으로 분할하는 기술로, 표준 곡선을 사용하지 않고도 표적 핵산의 정밀한 절대 정량을 실현합니다. 참조 표준에 의존하고 저농도 표적에서 정확도가 부족할 수 있는 기존 정량 PCR과 달리 dPCR은 더 높은 정확도를 제공합니다. 예를 들어, 2024년 9월 독일에 본사를 둔 생명공학 기업 QIAGEN N.V.(QIAGEN N.V.)은 임상용 dPCR 플랫폼 'QIAcuityDx 디지털 PCR 시스템'을 발표하였습니다. 이 시스템은 분할, 써모사이클링, 이미징을 단일 자동화 장비에 통합하여 액체 생검을 기반으로 한 암 모니터링과 같은 응용 분야에서 DNA와 RNA의 정확한 정량화를 가능하게 합니다. 본 플랫폼은 유럽 IVDR 인증, 미국 510(k) 면제, 직관적인 소프트웨어, 유연한 스케줄링, GeneGlobe 플랫폼을 통한 동반진단 개발 지원 등을 특징으로 합니다. QIAcuityDx 시스템은 수작업을 줄여 실험실의 효율성을 향상시키는 동시에 저농도의 표적 분자에 대해서도 일관되고 신뢰할 수 있는 결과를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Diagnostic enzymes are enzymes that are used either directly or as components of assay systems to identify the presence or absence of various compounds, helping to detect, diagnose, or predict the progression of disease conditions. They are widely applied in diagnostics due to their high substrate specificity and measurable activity, even in the presence of other proteins.
The primary product types in the diagnostic enzymes market include carbohydrases, polymerases, nucleases, proteases, and others. Carbohydrases are a class of enzymes, such as amylase, that facilitate the breakdown or synthesis of carbohydrates, including disaccharides. These enzymes are sourced from animals, microorganisms, and plants and are used across applications such as biocatalysts, diagnostics, pharmaceuticals, research, and biotechnology.
Tariffs have impacted the diagnostic enzyme market by raising costs for imported high-purity enzymes, reagents, and laboratory equipment, particularly affecting segments like polymerases, nucleases, and proteases. Regions such as North America and Europe, which depend heavily on imports from Asia-Pacific manufacturing hubs, are most affected. While tariffs have increased operational costs and slowed procurement, they have also incentivized local enzyme production, development of cost-effective alternatives, and innovation in diagnostic assay technologies.
The diagnostic enzyme market research report is one of a series of new reports from The Business Research Company that provides diagnostic enzyme market statistics, including diagnostic enzyme industry global market size, regional shares, competitors with a diagnostic enzyme market share, detailed diagnostic enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic enzyme industry. This diagnostic enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diagnostic enzyme market size has grown strongly in recent years. It will grow from $4.49 billion in 2025 to $4.75 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of high-purity diagnostic enzymes, reliance on traditional assay methods, increasing prevalence of chronic diseases, growing biotechnology and research initiatives, rising awareness of enzyme-based diagnostics.
The diagnostic enzyme market size is expected to see strong growth in the next few years. It will grow to $6.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of advanced enzyme engineering techniques, integration of diagnostics with digital health platforms, rising adoption of point-of-care testing, expansion of pharmaceutical and biotech R&D, increasing government and private funding for diagnostic innovations. Major trends in the forecast period include rising adoption of enzyme-based diagnostic kits, growth in personalized medicine and biomarker detection, expansion of research and biotechnology applications, increasing demand for high-specificity and sensitive enzymes, integration of enzyme diagnostics in point-of-care testing.
The increasing prevalence of chronic diseases is expected to drive the growth of the diagnostic enzymes market in the coming years. Chronic diseases are long-term health conditions that persist for three months or longer. Diagnostic enzymes play a critical role in the diagnosis and ongoing monitoring of chronic diseases and other medical conditions by enabling healthcare professionals to evaluate disease severity, track treatment effectiveness, and make informed adjustments to care plans. For example, in January 2023, according to the National Library of Medicine, a US-based agency, the population in the United States aged 50 years and older with at least one chronic condition is projected to rise by 99.5%, increasing from 71.522 million to 142.66 million by 2050. Therefore, the growing burden of chronic diseases is contributing to the expansion of the diagnostic enzymes market.
Major companies operating in the diagnostic enzymes market are increasingly emphasizing technological innovations, such as digital PCR platforms, to address the rising demand for highly sensitive and absolute quantification in clinical diagnostics, particularly in oncology and infectious disease testing. Digital PCR (dPCR) is a technique that divides a sample into thousands of nanoliter-scale reactions, enabling precise absolute quantification of target nucleic acids without the need for standard curves. Unlike traditional quantitative PCR, which relies on reference standards and may lack accuracy at low target levels, dPCR delivers greater precision. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, launched the QIAcuityDx Digital PCR System, a clinical-grade dPCR platform. This system combines partitioning, thermocycling, and imaging within a single automated device, allowing accurate DNA and RNA quantification for applications such as liquid biopsy-based cancer monitoring. The platform features IVDR certification in Europe, 510(k) exemption in the United States, intuitive software, flexible scheduling, and support for companion diagnostic development through the GeneGlobe platform. The QIAcuityDx system improves laboratory efficiency by reducing manual handling while delivering consistent and reliable results, even for low-abundance targets.
In January 2023, SD Biosensor Inc., a South Korea-based provider of in vitro diagnostic platforms and rapid testing systems, together with its partner SJL Services Private Limited, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor sought to accelerate its expansion into the US in vitro diagnostics market by leveraging Meridian Bioscience's established regulatory expertise and distribution network. Meridian Bioscience Inc. is a US-based company specializing in diagnostic testing solutions and life-science raw materials.
Major companies operating in the diagnostic enzyme market are Sanofi S.A., Advanced Enzymes Technologies, Aldevron LLC, Amano Enzymes Inc., Codexis Inc., EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc., Amgen Inc., Biogen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc.
North America was the largest region in the enzymes market in 2025. Middle East is expected to be the fastest-growing region in the diagnostic enzyme market report during the forecast period. The regions covered in the diagnostic enzyme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diagnostic enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diagnostic enzymes market consists of sales of acid phosphatase, alanine aminotransferase, cholinesterase, and aspartate aminotransferase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the diagnostic enzymes market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diagnostic Enzyme Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses diagnostic enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diagnostic enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic enzyme market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Carbohydrases; Polymerases And Nucleases; Protease; Other Product Types
2) By Source: Animals; Microorganisms; Plants
3) By Application: Biocatalysts; Diagnostics; Pharmaceuticals; Research & Biotechnology
Subsegments:
1) By Carbohydrases: Amylases; Cellulases; Lactases; Glucosidases
2) By Polymerases And Nucleases: DNA Polymerases; RNA Polymerases; Restriction Endonucleases; Exonucleases
3) By Protease: Serine Proteases; Cysteine Proteases; Metalloproteases; Aspartic Proteases
4) By Other Product Types: Oxidoreductases; Transferases; Lyases; Hydrolases
Companies Mentioned: Sanofi S.A.; Advanced Enzymes Technologies; Aldevron LLC; Amano Enzymes Inc.; Codexis Inc.; EKF Diagnostic; Kaneka Eurogentec; Roche Holding AG; Sekisui Diagnostics LLC; Thermo Fisher Scientific Inc.; Charles River Laboratories; Biocatalysts; Merck & Co. Inc.; Chr. Hansen; Kerry Group; Dyadic International; Creative Enzymes; Pfizer Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Johnson & Johnson; AbbVie Inc.; Amgen Inc.; Biogen Inc.; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Enzyme-Based Diagnostic Kits
4.2.2 Growth In Personalized Medicine And Biomarker Detection
4.2.3 Expansion Of Research And Biotechnology Applications
4.2.4 Increasing Demand For High-Specificity And Sensitive Enzymes
4.2.5 Integration Of Enzyme Diagnostics In Point-Of-Care Testing
5. Diagnostic Enzyme Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Research Laboratories
5.3 Biotechnology Companies
5.4 Hospitals And Diagnostic Centers
5.5 Academic And Clinical Research Institutions
6. Diagnostic Enzyme Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Diagnostic Enzyme Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Diagnostic Enzyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Diagnostic Enzyme Market Size, Comparisons And Growth Rate Analysis
7.3. Global Diagnostic Enzyme Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Diagnostic Enzyme Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Diagnostic Enzyme Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Diagnostic Enzyme Market Segmentation
9.1. Global Diagnostic Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Carbohydrases, Polymerases And Nucleases, Protease, Other Product Types
9.2. Global Diagnostic Enzyme Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Animals, Microorganisms, Plants
9.3. Global Diagnostic Enzyme Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology
9.4. Global Diagnostic Enzyme Market, Sub-Segmentation Of Carbohydrases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Amylases, Cellulases, Lactases, Glucosidases
9.5. Global Diagnostic Enzyme Market, Sub-Segmentation Of Polymerases And Nucleases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
DNA Polymerases, RNA Polymerases, Restriction Endonucleases, Exonucleases
9.6. Global Diagnostic Enzyme Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Diagnostic Enzyme Market
12.1. China Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Diagnostic Enzyme Market
13.1. India Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Diagnostic Enzyme Market
14.1. Japan Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Diagnostic Enzyme Market
15.1. Australia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Diagnostic Enzyme Market
16.1. Indonesia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Diagnostic Enzyme Market
17.1. South Korea Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Diagnostic Enzyme Market
18.1. Taiwan Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Diagnostic Enzyme Market
19.1. South East Asia Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Diagnostic Enzyme Market
20.1. Western Europe Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Diagnostic Enzyme Market
21.1. UK Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Diagnostic Enzyme Market
22.1. Germany Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Diagnostic Enzyme Market
23.1. France Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Diagnostic Enzyme Market
24.1. Italy Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Diagnostic Enzyme Market
25.1. Spain Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Diagnostic Enzyme Market
26.1. Eastern Europe Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Diagnostic Enzyme Market
27.1. Russia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Diagnostic Enzyme Market
28.1. North America Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Diagnostic Enzyme Market
29.1. USA Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Diagnostic Enzyme Market
30.1. Canada Diagnostic Enzyme Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Diagnostic Enzyme Market
31.1. South America Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Diagnostic Enzyme Market
32.1. Brazil Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Diagnostic Enzyme Market
33.1. Middle East Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Diagnostic Enzyme Market
34.1. Africa Diagnostic Enzyme Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Diagnostic Enzyme Market Regulatory and Investment Landscape
36. Diagnostic Enzyme Market Competitive Landscape And Company Profiles
36.1. Diagnostic Enzyme Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Diagnostic Enzyme Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Diagnostic Enzyme Market Company Profiles
36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Advanced Enzymes Technologies Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Aldevron LLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Amano Enzymes Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Codexis Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Diagnostic Enzyme Market Other Major And Innovative Companies
EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company
38. Global Diagnostic Enzyme Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Diagnostic Enzyme Market
40. Diagnostic Enzyme Market High Potential Countries, Segments and Strategies
40.1 Diagnostic Enzyme Market In 2030 - Countries Offering Most New Opportunities
40.2 Diagnostic Enzyme Market In 2030 - Segments Offering Most New Opportunities
40.3 Diagnostic Enzyme Market In 2030 - Growth Strategies
